|
1
|
DeVries JH, Desouza C, Bellary S, Unger J, Bangsgaard EO, Zacho J, Woo V, Jacob S. Mehr Patienten unter Semaglutid erreichten ein HbA1c unter 7% ohne Gewichtszunahme, Hypoglykämie und gastrointestinale Ereignisse, im Vergleich zu Komparatoren in den Studien SUSTAIN 1 – 5. DIABETOL STOFFWECHS 2018. [DOI: 10.1055/s-0038-1641898] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- JH DeVries
- University of Amsterdam, Amsterdam, Netherlands
| | - C Desouza
- University of Nebraska Medical Center, Omaha, United States
| | - S Bellary
- Aston University, Birmingham, United Kingdom
| | - J Unger
- Catalina Research Institute, Chino, United States
| | | | - J Zacho
- Novo Nordisk, Søborg, Denmark
| | - V Woo
- Novo Nordisk, Søborg, Denmark
| | - S Jacob
- Internist, Endokrinologe und Diabetologe, Kardio-Metabolisches Institut, Villingen-Schwenningen, Germany
| |
Collapse
|